시장보고서

상품코드

1831853

초붕괴제 시장 보고서 : 제품, 유형, 제형, 치료 분야, 지역별(2025-2033년)

Superdisintegrants Market Report by Product, Type, Dosage Form, Therapeutic Areas, and Region 2025-2033

발행일: 2025년 10월 | 리서치사:

IMARC | 페이지 정보: 영문 142 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 초붕괴제 시장 규모는 2024년에 4억 4,300만 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 7억 6,680만 달러에 달하며, 2025-2033년에 5.97%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다.

초붕괴제는 정제나 캡슐을 더 작은 입자로 분할 또는 붕괴시키기 위해 의약품 제제에 첨가되는 개량형 붕괴제입니다. 약물의 흡수를 촉진하고 체내 유효성분(API)의 용해도를 높여 붕괴 시간을 단축하고 경구용 고체 제제의 효율을 높입니다. 이들은 고체 제형에서 낮은 수준으로 사용되며, 일반적으로 제형의 총 중량 대비 1-10 중량%입니다. 현재 합성 및 천연 변이체가 존재하며, 심혈관 질환, 감염성 질환, 혈액 질환, 신경질환, 소화기 질환, 염증성 질환 등 다양한 치료 분야에서 사용되고 있습니다.

초붕괴제 시장 동향 :

현재 제약업계에서 고형제가 큰 비중을 차지하고 있습니다. 이는 다양한 노화 관련 질환 및 만성질환을 앓고 있는 사람들 증가와 함께 시장 성장을 강화하는 중요한 요인 중 하나가 되고 있습니다. 또한 항정신병제, 항우울제, 항편두통약, 진정제 등 구강붕해정제(ODT) 제조에 초붕해제를 광범위하게 사용함으로써 업계 투자자들에게 유리한 성장 기회를 제공합니다. 이 외에도 높은 호환성, 생체 이용률 향상, 효율적인 압축성 등의 특징이 전 세계에서 초붕괴제에 대한 수요를 불러일으키고 있습니다. 또한 주요 기업은 시장 경쟁력을 유지하기 위해 제품 개발 및 새로운 제형 혁신에 상당한 투자를 하고 있습니다. 또한 엄격한 규제로 인해 제약업계는 보다 안전한 대체품의 사용을 촉진하고 있으며, 이는 천연 초붕괴제의 세계 보급을 촉진하고 있습니다. 또한 코로나바이러스 감염증(COVID-19)의 유행으로 인한 원격의료의 인기 증가와 함께 신경질환의 부담이 증가하고 있는 것도 시장 성장을 가속할 것으로 예측됩니다.

이 보고서에서 다룬 주요 질문

세계 초붕괴제 시장은 지금까지 어떻게 성장하며 왔는가?
COVID-19가 세계 초붕괴제 시장에 미치는 영향은?
주요 지역 시장은?
제품별 시장 분석은?
유형별 시장 분석은?
제형별 시장 현황은?
치료 분야별 시장 현황은?
산업 밸류체인의 다양한 단계는?
업계의 주요 촉진요인과 과제는?
세계 초붕괴제 시장 구조와 주요 기업은?
업계내 경쟁은 어느 정도인가?

시장 구조
주요 기업
주요 기업의 개요
- Asahi Kasei Corporation
- Ashland Global Specialty Chemicals Inc.
- Avantor Inc.
- BASF SE
- Corel Pharma Chem
- DFE Pharma GmbH & Co. KG
- DuPont de Nemours Inc.
- JRS Pharma GmbH & Co. KG
- Merck KGaA
- Nippon Soda Co. Ltd.
- Roquette Freres
- Sigachi Industries Limited

KSA

The global superdisintegrants market size reached USD 443.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 766.8 Million by 2033, exhibiting a growth rate (CAGR) of 5.97% during 2025-2033.

Superdisintegrants are modified disintegrants added in drug formulations to facilitate the breakup or disintegration of tablets or capsules into smaller particles. They assist in increasing the absorption of the drug and the solubility of active pharmaceutical ingredients (APIs) in the body, thereby reducing the disintegration time or oral solid dosage forms and enhancing their efficiency. They are utilized at a low level in the solid dosage form, generally 1- 10% by weight relative to the total weight of the dosage unit. Presently, they are available in synthetic and natural variants and used in many therapeutic areas, such as cardiovascular, infectious, hematological, neurological, gastrointestinal diseases, and inflammatory diseases.

Superdisintegrants Market Trends:

Solid dosage medicines currently hold a significant share in the pharmaceutical industry. This, coupled with the rising number of people suffering from various age-related and chronic diseases, represents one of the key factors strengthening the growth of the market. Moreover, the extensive usage of superdisintegrants in the production of orally disintegrating tablets (ODTs) for antipsychotics, antidepressants, antimigraine, and sedatives is offering lucrative growth opportunities to industry investors. Apart from this, features like high compatibility, improved bioavailability, and efficient compressibility are catalyzing the demand for superdisintegrants worldwide. Additionally, leading players are considerably investing in product development and innovation of novel formulations to retain a competitive edge in the market. Besides this, stringent regulations are propelling the use of safer alternatives in the pharmaceutical industry, which is assisting in the wider acceptance of natural superdisintegrants around the world. Furthermore, the growing burden of neurological disorders, in confluence with the increasing popularity of telemedicine on account of the coronavirus disease (COVID-19) outbreak, is anticipated to impel the market growth.

Key Market Segmentation:

Breakup by Product:

Croscarmellose Sodium
Crospovidone
Sodium Starch Glycolate
Ion Exchange Resin
Modified Cellulose
Others

Breakup by Type:

Natural Superdisintegrant
Synthetic Superdisintegrant
Others

Breakup by Dosage Form:

Tablets and Capsules
Mouth-Dissolving Films

Breakup by Therapeutic Areas:

Gastrointestinal
Cardiovascular
Neurology
Oncology
Hematology
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, Ashland Global Specialty Chemicals Inc., Avantor Inc., BASF SE, Corel Pharma Chem, DFE Pharma GmbH & Co. KG, DuPont de Nemours Inc., JRS Pharma GmbH & Co. KG, Merck KGaA, Nippon Soda Co. Ltd., Roquette Freres and Sigachi Industries Limited.

Key Questions Answered in This Report:

How has the global superdisintegrants market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global superdisintegrants market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the type?
What is the breakup of the market based on the dosage form?
What is the breakup of the market based on the therapeutic areas?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global superdisintegrants market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Superdisintegrants Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Croscarmellose Sodium
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Crospovidone
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Sodium Starch Glycolate
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Ion Exchange Resin
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Modified Cellulose
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast

7 Market Breakup by Type

7.1 Natural Superdisintegrant
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Synthetic Superdisintegrant
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Dosage Form

8.1 Tablets and Capsules
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Mouth-Dissolving Films
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Therapeutic Areas

9.1 Gastrointestinal
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Cardiovascular
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Neurology
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Oncology
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Hematology
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
9.6 Others
- 9.6.1 Market Trends
- 9.6.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Asahi Kasei Corporation
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Ashland Global Specialty Chemicals Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Avantor Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
- 15.3.4 BASF SE
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Corel Pharma Chem
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 DFE Pharma GmbH & Co. KG
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 DuPont de Nemours Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 JRS Pharma GmbH & Co. KG
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Merck KGaA
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Nippon Soda Co. Ltd.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Roquette Freres
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 SWOT Analysis
- 15.3.12 Sigachi Industries Limited
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio

초붕괴제 시장 보고서 : 제품, 유형, 제형, 치료 분야, 지역별(2025-2033년)

Superdisintegrants Market Report by Product, Type, Dosage Form, Therapeutic Areas, and Region 2025-2033

초붕괴제 시장 동향 :

이 보고서에서 다룬 주요 질문

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 개요

제4장 서론

제5장 세계의 초붕괴제시장

제6장 시장 내역 : 제품별

제7장 시장 내역 : 유형별

제8장 시장 내역 : 제형별

제9장 시장 내역 : 치료 분야별

제10장 시장 내역 : 지역별

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porter's Five Forces 분석

제14장 가격 분석

제15장 경쟁 구도